Bone Biologics Corp. (BBLG) vs Carisma Therapeutics Inc. (CARM)

Bone Biologics Corp. and Carisma Therapeutics Inc. are both Biotechnology companies. Carisma Therapeutics Inc. is the larger, with a market value of $1.5M against $1.4M — 1.1× the size. Carisma Therapeutics Inc. has the higher net margin (14.4% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, Carisma Therapeutics Inc. leads on 6 and Bone Biologics Corp. on 4.

Valuation

Metric BBLG CARM Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 0.22 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m (0.05) 10.73
Earnings yield (285.42%) 0.00% (28.84%)
Free cash flow yield (304.81%) 0.00% (23.03%)

Profitability

Metric BBLG CARM Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% 19.36% 0.00%
Net margin 0.00% 14.36% 0.00%
Free cash flow margin 0.00% (38.79%) 0.00%
Return on equity (54.96%) (134.11%) (57.72%)
Return on assets (50.55%) 33.09% (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BBLG CARM Biotechnology median
Revenue growth (TTM) — 170.48% 5.64%
EPS growth (last fiscal year) 90.85% 43.68% —
Revenue growth, 5-year CAGR — 115.24% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BBLG CARM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.67 0.86 4.73
Net debt to EBITDA 1.65 0.30 0.96

Dividend

Metric BBLG CARM Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BBLG CARM Biotechnology median
Market cap 1.35m 1.52m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack